IRIS
DAMIANO, Rocco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.965
AS - Asia 2.700
EU - Europa 1.132
Continente sconosciuto - Info sul continente non disponibili 516
SA - Sud America 470
AF - Africa 57
OC - Oceania 4
Totale 9.844
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.793
SG - Singapore 1.255
CN - Cina 682
IT - Italia 491
BR - Brasile 359
IN - India 280
VN - Vietnam 217
GB - Regno Unito 161
CA - Canada 124
SE - Svezia 122
DE - Germania 106
HK - Hong Kong 78
FI - Finlandia 49
AR - Argentina 40
FR - Francia 34
BD - Bangladesh 32
MX - Messico 31
JP - Giappone 30
ID - Indonesia 26
NL - Olanda 25
UA - Ucraina 24
ZA - Sudafrica 20
EC - Ecuador 18
RU - Federazione Russa 18
ES - Italia 17
PL - Polonia 17
CO - Colombia 13
CZ - Repubblica Ceca 13
CL - Cile 12
IQ - Iraq 11
RO - Romania 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
TR - Turchia 9
AZ - Azerbaigian 8
BE - Belgio 8
EG - Egitto 8
MA - Marocco 8
AT - Austria 7
CH - Svizzera 7
JM - Giamaica 7
UZ - Uzbekistan 7
EU - Europa 6
PE - Perù 6
VE - Venezuela 6
IL - Israele 5
KE - Kenya 4
KR - Corea 4
LB - Libano 4
LT - Lituania 4
MY - Malesia 4
OM - Oman 4
PK - Pakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
TW - Taiwan 4
AU - Australia 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
IR - Iran 3
NO - Norvegia 3
NP - Nepal 3
UY - Uruguay 3
AO - Angola 2
BY - Bielorussia 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MV - Maldive 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 9.331
Salva come PNG Salva come JPEG
Città #
San Jose 906
Chandler 514
Dallas 480
Ashburn 421
Singapore 384
Santa Clara 240
Hefei 202
Bengaluru 201
Milan 199
Princeton 186
Lawrence 185
London 122
Chicago 120
Wilmington 109
Beijing 107
Ottawa 86
Ho Chi Minh City 81
Hong Kong 76
Munich 76
Des Moines 65
Los Angeles 59
Boardman 47
Hanoi 47
The Dalles 39
Catanzaro 38
New York 38
Columbus 37
São Paulo 35
Turku 31
Council Bluffs 26
Orem 24
Shanghai 22
Tokyo 22
Rome 20
Brooklyn 19
Helsinki 18
Guangzhou 17
Pune 17
Boston 16
Montreal 16
Norwalk 16
Warsaw 16
Chennai 15
Shenzhen 15
Bagneux 14
Atlanta 13
Houston 12
San Francisco 12
Toronto 12
West Jordan 12
Amsterdam 11
Falls Church 11
Johannesburg 11
Olomouc 11
Redmond 11
Seattle 11
Altavilla Irpina 10
Ann Arbor 10
Haiphong 10
Mumbai 10
Stockholm 10
Wuhan 10
Florence 9
Rio de Janeiro 9
Baku 8
Curitiba 8
Da Nang 8
Hanover 8
Manchester 8
Mexico City 8
Biên Hòa 7
Fairfield 7
Naples 7
Redwood City 7
Tashkent 7
Augusta 6
Bologna 6
Charlotte 6
Denver 6
Goiânia 6
Guayaquil 6
Ha Long 6
Kingston 6
Manaus 6
Paris 6
Phoenix 6
Ankara 5
Brasília 5
Fortaleza 5
Guarulhos 5
Jakarta 5
Moscow 5
Raleigh 5
Rui'an 5
Santiago 5
Santo André 5
Venice 5
Washington 5
Zurich 5
Buenos Aires 4
Totale 5.847
Salva come PNG Salva come JPEG
Nome #
64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality? 115
Effects of One-Shot Hyaluronic Acid Injection in Lifelong Premature Ejaculation: A Pilot Study 107
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 102
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 93
Long-term recovery of normal sexual function in testicular cancer survivors. 90
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 88
Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI). 86
Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible. R. Autorino, G. De Lorenzo 84
Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: A systematic review. 84
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. 83
Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study. 81
Comparison Between (64)Cu-PSMA-617 PET/CT and (18)F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical Recurrence. 80
Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar? 79
A larger detrusor wall thickness increases the risk of non muscle invasive bladder cancer recurrence and progression: result from a multicenter observational study. 77
An alternative approach for the identification of potential prostate cancer biomarkers 77
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. 77
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 77
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. 76
Altered Metalloproteinase-9 expression as the least common denominator between Varicocele, Inguinal Hernia and Chronic Venous Disorders 76
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma 75
30. How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature 73
8. Early and late complications of ureteral stent 72
Detection Rate of Prostate-Specific Membrane Antigen Tracers for Positron Emission Tomography/Computed Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis 70
Contemporary urologic minilaparoscopy: indications, techniques, and surgical outcomes in a multi-institutional European cohort. 69
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 67
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 66
Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy. 66
Metabolic syndrome in white European men presenting for primary couple's infertility: investigation of the clinical and reproductive burden. 66
High-throughput detection of low abundance sialylated glycoproteins in human serum by TiO2 enrichment and targeted LC-MS/MS analysis: application to a prostate cancer sample set 66
Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. 66
Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer? 65
PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer 65
Are abstracts presented at the EAU Meeting followed by fublications in peer Reviewed Journals? 64
Are extended biopsies really necessary to improve prostate cancer detection? 64
Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches. 63
An update on prostate biopsy in the era of magnetic resonance imaging 63
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 63
The need to reduce patient discomfort during ultrasonography-guided prostate biopsy: what do we know ? 62
Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. 61
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer. 61
Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 Evaluation 61
Prevalence and predictors of concomitant low sexual desire/interest and new-onset erectile dysfunction - a picture from the everyday clinical practice. 60
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 60
Evaluation of accuracy and reproducibility of a novel method for measuring penile curvature in Peyronie’s disease: the Check Him mobile application 60
5. Prevalence of faecal incontinence among women with urinary incontinence 59
Metabolic syndrome correlates with peri-urethral fibrosis secondary to chronic prostate inflammation: evidence of a link in a cohort of patients undergoing radical prostatectomy. 59
Sperm banking is of key importance in patients with prostate cancer. 59
Hypovitaminosis D and low urinary tract symptoms in a female population 59
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer : a multi-institutional, long-term experience 59
The impact the COVID-19 pandemic on urology literature: a bibliometric analysis 58
Avanafil - a further step to tailoring patient needs and expectations. 58
Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies 58
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 58
Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis 57
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 57
Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey. 56
Latest Evidence On The Role Of Multiparametric Magnetic Resonance Imaging In Active Surveillance For Insignificant Prostate Cancer: A Systematic Review 56
Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs. 56
Haemostatic agents during laparoscopic nephron-sparing surgery: what about TachoSil? 56
Fate of abstracts presented at the World Congress of Endourology: are they followed by pubblication in peer-reviewed journals? 56
The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment 55
Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis 55
One patient out of four with newly diagnosed erectile dysfunction is a young man-worrisome picture from the everyday clinical practice. 54
Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infecti 54
Economic evaluation of a new non-antibiotic 1st-line treatment of rUTI 54
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 54
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis 54
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 53
Metabolic Syndrome, Obesity, and Radical Cystectomy Complications: A Clavien Classification System-Based Analysis. 53
Questionnaire based evaluation of prostate cancer biopsy complication comparing different bioptic schemes 53
Retropubic, laparoscopic and mini-laparoscopic radical prostatectomy: a prospective assessment of patient scar satisfaction. 52
Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer. 52
Results and complications of laparoscopic surgery for pediatric varicocele. 52
Stent positioning after ureteroscopy for urinary calculi: the question is still open 52
Estimated Glomerular Filtration Rate Decline at 1 Year After Minimally Invasive Partial Nephrectomy: A Multimodel Comparison of Predictors 51
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study. 51
Three-dimensional vs standard laparoscopy: comparative assessment using a validated program for laparoscopic urologic skills. 51
Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link. 51
Pelvic plexus block is more effective than periprostatic nerve block for pain control during office transrectal ultrasound guided prostate biopsy: A single center, prospective, randomized, double arm study 51
Diagnostic Accuracy of (64)Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience 51
Beyond PSA: The role of prostate health index (phi) 51
Transrectal contrast-enhanced ultrasonography, transrectal ultrasonography and retrograde cystography for the detection of vesicourethral anastomosis leakage after radical retropubic prostatectomy: a prospective comparative evaluation. 51
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer 50
Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study. 50
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 50
Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy 49
Sexual outcome following photoselective vaporization of the prostate: is there enough evidence? 49
PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance. 49
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 49
Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: a prospective single cohort study. 48
Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study 48
Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey. 48
Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. 48
External validation of the european Association of Urology recommendations for lymph node dissection in patients treated with robotic-assisted radical prostatectomy. 48
Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy. 48
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 47
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables 47
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. 47
The emerging role of obesity, diet and lipid metabolism in prostate cancer Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 47
Restoring the glycosaminoglycans layer in recurrent cystitis: Experimental and clinical foundations 47
Totale 6.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022833 0 2 7 471 11 10 28 108 61 28 86 21
2022/20231.564 377 26 46 133 190 142 94 111 249 87 95 14
2023/2024622 140 88 50 37 31 149 14 21 12 23 14 43
2024/20252.062 288 204 99 56 92 249 40 97 278 133 219 307
2025/20264.394 224 558 500 634 410 191 623 267 449 357 123 58
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 9.844